The role of cerebral ischemia in Alzheimer’s disease

[1]  T. Kudo,et al.  Are cerebrovascular factors involved in Alzheimer’s disease? , 2000, Neurobiology of Aging.

[2]  I. McKeith,et al.  Neuropathological Substrates of Dementia and Depression in Vascular Dementia, with a Particular Focus on Cases with Small Infarct Volumes , 2000, Dementia and Geriatric Cognitive Disorders.

[3]  J. Guridi,et al.  High frequency stimulation of the subthalamic nucleus and levodopa induced dyskinesias in Parkinson's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[4]  Y. Stern,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[5]  A. Hofman,et al.  The effect of APOE on dementia is not through atherosclerosis: the Rotterdam Study. , 1999, Neurology.

[6]  Zsuzsanna Nagy,et al.  Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease , 1999, The Lancet.

[7]  N. Delanty,et al.  Neuroprotective properties of statins in cerebral ischemia and stroke. , 1999, Stroke.

[8]  A. Onipinla,et al.  A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. , 1999, Journal of hypertension.

[9]  C. Pang,et al.  Lipoprotein lipase mutations and Alzheimer's disease. , 1999, American journal of medical genetics.

[10]  S. DeKosky,et al.  A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease , 1999, Neuroscience Letters.

[11]  L. Wahlund,et al.  White Matter Lesions in Alzheimer Patients Are Influenced by Apolipoprotein E Genotype , 1999, Dementia and Geriatric Cognitive Disorders.

[12]  Jimmy D Bell,et al.  Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training , 1999, The Lancet.

[13]  D. Borchelt,et al.  SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.

[14]  P. Mehta,et al.  Traumatic Brain Injury Increases β‐Amyloid Peptide 1‐42 in Cerebrospinal Fluid , 1998 .

[15]  M. Emmerling,et al.  Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. , 1998, Biochemical and biophysical research communications.

[16]  R Clarke,et al.  Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.

[17]  Yu-Min Kuo,et al.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.

[18]  A. Smith,et al.  Comparison of Pathological Diagnostic Criteria for Alzheimer Disease , 1998, Alzheimer disease and associated disorders.

[19]  J. Hardy,et al.  Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. , 1998, Human molecular genetics.

[20]  C. Broeckhoven,et al.  Risk of Left Ventricular Dysfunction in Patients with Probable Alzheimer's Disease with APOE*4 Allele , 1998, Journal of the American Geriatrics Society.

[21]  R. Mohs,et al.  Cerebral infarcts in patients with autopsy-proven Alzheimer's disease , 1998, Neurology.

[22]  B. Strooper,et al.  Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Blass,et al.  Absence of Vascular Dementia in an Autopsy Series from a Dementia Clinic , 1998, Journal of the American Geriatrics Society.

[24]  K. Blennow,et al.  A population study on blood-brain barrier function in 85-year-olds , 1998, Neurology.

[25]  T. Kudo,et al.  Alzheimer-associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia. , 1998, Brain research. Molecular brain research.

[26]  R. Schmidt,et al.  β-Fibrinogen Gene Polymorphism (C148→T) Is Associated With Carotid Atherosclerosis , 1998 .

[27]  M. Margaglione,et al.  Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study. , 1998, Stroke.

[28]  Irma-Leena Notkola,et al.  Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease , 1998, Neuroepidemiology.

[29]  D. Rizzoni,et al.  Alpha‐adducin gene polymorphism and cardiovascular phenotypes in a general population , 1997, Journal of hypertension.

[30]  D. Leys,et al.  Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. , 1997, Stroke.

[31]  M. Esiri,et al.  Neuropathological assessment of the lesions of significance in vascular dementia , 1997, Journal of neurology, neurosurgery, and psychiatry.

[32]  A. Hofman,et al.  Dietary fat intake and the risk of incident dementia in the Rotterdam study , 1997, Annals of neurology.

[33]  J. Torre,et al.  Hemodynamic Consequences of Deformed Microvessels in the Brain in Alzheimer's Disease , 1997 .

[34]  Julie H. Campbell,et al.  The cell biology of atherosclerosis--new developments. , 1997, Australian and New Zealand journal of medicine.

[35]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[36]  R. Kalaria.  Arteriosclerosis, apolipoprotein E, and Alzheimer's disease , 1997, The Lancet.

[37]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[38]  I. Skoog,et al.  Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. , 1997, Archives of neurology.

[39]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[40]  A. Hofman,et al.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.

[41]  P. Amouyel,et al.  The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment , 1996, Neuroscience Letters.

[42]  L. Thal,et al.  The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant , 1996, Neurology.

[43]  R N Kalaria,et al.  Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. , 1996, The American journal of pathology.

[44]  D. Wilcken,et al.  Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. , 1996, Circulation.

[45]  V Hachinski,et al.  Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. , 1996, Archives of neurology.

[46]  C. Martyn,et al.  Cognitive impairment and mortality in a cohort of elderly people , 1996, BMJ.

[47]  D. W. Desmond,et al.  COGNITIVE IMPAIRMENT AND RISK OF STROKE IN THE OLDER POPULATION , 1996, Journal of the American Geriatrics Society.

[48]  W. O'Fallon,et al.  Dementia after ischemic stroke , 1996, Neurology.

[49]  K. Blennow,et al.  Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? , 1995, Molecular and chemical neuropathology.

[50]  K. Blennow,et al.  A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[51]  C. Sing,et al.  Impact of apolipoprotein E genotype variation on means, variances, and correlations of plasma lipid, lipoprotein, and apolipoprotein traits in octogenarians. , 1995, American journal of medical genetics.

[52]  L. Thal,et al.  Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. , 1995, Archives of neurology.

[53]  H. Soininen,et al.  Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. , 1995, Stroke.

[54]  L. Chang,et al.  Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease. , 1995, Annals of clinical and laboratory science.

[55]  P. Hedera,et al.  Differential degeneration of the cerebral microvasculature in Alzheimer's disease. , 1995, Neuroreport.

[56]  D. Graham,et al.  Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury , 1995, Nature Medicine.

[57]  P A Wolf,et al.  Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. , 1994, JAMA.

[58]  G. Frisoni,et al.  Apolipoprotein E ε4 Allele in Alzheimer's Disease and Vascular Dementia , 1994 .

[59]  D. Graham,et al.  Microglial interleukin-lα expression in human head injury: Correlations with neuronal and neuritic β-amyloid precursor protein expression , 1994, Neuroscience Letters.

[60]  J. Kimura,et al.  Temporal Profiles of Accumulation of Amyloid β/A4 Protein Precursor in the Gerbil after Graded Ischemic Stress , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[61]  Y. Ihara,et al.  Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus. , 1994, The Journal of biological chemistry.

[62]  A. Brun,et al.  Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. , 1994, Dementia.

[63]  L. Murray,et al.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[64]  K. Beyreuther,et al.  Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and nondemented controls. , 1994, Dementia.

[65]  R. Kalaria,et al.  The Amyloid Precursor Protein in Ischemic Brain Injury and Chronic Hypoperfusion a , 1993, Annals of the New York Academy of Sciences.

[66]  I. Skoog,et al.  A population-based study of dementia in 85-year-olds. , 1993, The New England journal of medicine.

[67]  R. Kalaria,et al.  Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. , 1993, Neuroreport.

[68]  C. Mamotte,et al.  Apolipoprotein ∈4 homozygosity in young men with coronary heart disease , 1992, The Lancet.

[69]  D. Stephenson,et al.  Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat , 1992, Brain Research.

[70]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[71]  M Revach,et al.  Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer's disease. , 1992, Archives of neurology.

[72]  M. Takeda,et al.  Amyloid β-protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection , 1992, Neuroscience Letters.

[73]  N. Otsuka,et al.  Rapid appearance of β-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury , 1991, Brain Research.

[74]  D. Graham,et al.  βA4 amyloid protein deposition in brain after head trauma , 1991, The Lancet.

[75]  B Bacci,et al.  Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. , 1991, The American journal of pathology.

[76]  R. Tanzi,et al.  Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex , 1991, Neuroscience Letters.

[77]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[78]  Robert B. Nelson,et al.  Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage , 1989, Neuron.

[79]  J. Adams,et al.  Ischaemic brain damage is still common in fatal non-missile head injury. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[80]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[81]  H. Vinters.  Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.

[82]  Y. Zhi.  Apolipoprotein E Alleles, Dyslipidemia,and Coronary Heart Disease , 2001 .

[83]  M. Owen,et al.  Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease , 1999, Nature Genetics.

[84]  P. Scheltens,et al.  The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.

[85]  J. Morris,et al.  A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia , 1998, Nature Genetics.

[86]  C. Kessler,et al.  The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[87]  R N Kalaria,et al.  Cerebral vessels in ageing and Alzheimer's disease. , 1996, Pharmacology & therapeutics.

[88]  D. Premkumar,et al.  Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease. , 1996, Brain research. Molecular brain research.

[89]  Kalaria Rn,et al.  The blood-brain barrier and cerebral microcirculation in Alzheimer disease. , 1992 .

[90]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[91]  A. Alzheimer.  Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .